<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report" xml:lang="en">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">World J Surg Oncol</journal-id>
      <journal-id journal-id-type="iso-abbrev">World J Surg Oncol</journal-id>
      <journal-title-group>
        <journal-title>World Journal of Surgical Oncology</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1477-7819</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">24099520</article-id>
      <article-id pub-id-type="pmc">3852596</article-id>
      <article-id pub-id-type="publisher-id">1477-7819-11-263</article-id>
      <article-id pub-id-type="doi">10.1186/1477-7819-11-263</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Successful combination chemotherapy with irinotecan hydrochloride and cisplatin for primary gastric small cell carcinoma: report of a case</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes" id="A1">
          <name>
            <surname>Funahashi</surname>
            <given-names>Hitoshi</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>funa84@med.nagoya-cu.ac.jp</email>
        </contrib>
        <contrib contrib-type="author" id="A2">
          <name>
            <surname>Miyai</surname>
            <given-names>Hirotaka</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>Miyai@med.nagoya-cu.ac.jp</email>
        </contrib>
        <contrib contrib-type="author" id="A3">
          <name>
            <surname>Wakasugi</surname>
            <given-names>Takehiro</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>wakasugi@med.nagoya-cu.ac.jp</email>
        </contrib>
        <contrib contrib-type="author" id="A4">
          <name>
            <surname>Ishiguro</surname>
            <given-names>Hideyuki</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>h-ishi@med.nagoya-cu.ac.jp</email>
        </contrib>
        <contrib contrib-type="author" id="A5">
          <name>
            <surname>Matsuo</surname>
            <given-names>Yoichi</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>matsuo@med.nagoya-cu.ac.jp</email>
        </contrib>
        <contrib contrib-type="author" id="A6">
          <name>
            <surname>Kimura</surname>
            <given-names>Masahiro</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>mkimura@med.nagoya-cu.ac.jp</email>
        </contrib>
        <contrib contrib-type="author" id="A7">
          <name>
            <surname>Takeyama</surname>
            <given-names>Hiromitsu</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>takeyama@med.nagoya-cu.ac.jp</email>
        </contrib>
      </contrib-group>
      <aff id="I1"><label>1</label>Department of Gastroenterological Surgery, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya 4678601, Japan</aff>
      <pub-date pub-type="collection">
        <year>2013</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>7</day>
        <month>10</month>
        <year>2013</year>
      </pub-date>
      <volume>11</volume>
      <fpage>263</fpage>
      <lpage>263</lpage>
      <history>
        <date date-type="received">
          <day>25</day>
          <month>7</month>
          <year>2013</year>
        </date>
        <date date-type="accepted">
          <day>27</day>
          <month>9</month>
          <year>2013</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2013 Funahashi et al.; licensee BioMed Central Ltd.</copyright-statement>
        <copyright-year>2013</copyright-year>
        <copyright-holder>Funahashi et al.; licensee BioMed Central Ltd.</copyright-holder>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0">
          <license-p>This is an open access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0">http://creativecommons.org/licenses/by/2.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <self-uri xlink:href="http://www.wjso.com/content/11/1/263"/>
      <abstract>
        <p>Primary gastric small cell carcinoma is a rare and aggressive malignant disease with a poor prognosis that was first reported in 1976 by Matsusaka <italic>et al</italic>. The incidence is very low and the clinicopathological features are similar to those of small cell lung carcinoma.</p>
        <p>We herein report a case of successful treatment by combination chemotherapy consisting of irinotecan hydrochloride and cisplatin for primary gastric small cell carcinoma. The patient was a 71-year-old male who was admitted to a local hospital with anemia. Gastrointestinal endoscopy revealed the presence of advanced gastric carcinoma at the upper region of the stomach. The patient underwent surgery, and the pathological diagnosis was small cell carcinoma due to the presence of the typical features of small round cells with scant cytoplasm that were positive for synaptophysin and chromogranin A in the resected specimen. The patient underwent subsequent combination chemotherapy, which provided him with over 1 year of survival and a good quality of life. We also present a review of the literature regarding chemotherapy for primary gastric small cell carcinoma.</p>
      </abstract>
      <kwd-group>
        <kwd>Small cell carcinoma</kwd>
        <kwd>Cisplatin</kwd>
        <kwd>Irinotecan hydrochloride</kwd>
        <kwd>Combination chemotherapy</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Background</title>
      <p>Gastric carcinoma is a widespread malignant disease, and the worldwide mortality and incidence rates are 6.4 and 8.7 per 100,000, respectively [<xref ref-type="bibr" rid="B1">1</xref>]. These rates are particularly high in Japan (27.3 and 60.4 per 100,000, respectively) [<xref ref-type="bibr" rid="B2">2</xref>]. Gastric small cell carcinoma (GSCC) was first described as a subtype of gastric carcinoma in 1976 by Matsuzaka <italic>et al</italic>. [<xref ref-type="bibr" rid="B3">3</xref>]. Currently, GSCC is defined as one of the neuroendocrine tumors (NETs) according to the World Health Organization classification. The biological characteristics and clinicopathological features of GSCC are similar to those of small cell lung carcinoma (SCLC) [<xref ref-type="bibr" rid="B4">4</xref>-<xref ref-type="bibr" rid="B6">6</xref>], but GSCC is known to be more aggressive and malignant compared to SCLC because GSCC is more resistant to chemotherapy [<xref ref-type="bibr" rid="B6">6</xref>]. Effective treatment strategies for GSCC have not yet been established, because it is very rare, with an incidence of about 0.02% of all gastric carcinomas, even in Japan. We believe that surgery and subsequent systemic chemotherapy represent an effective therapeutic approach for GSCC. Several reports have recommended using the same therapeutic strategies as those used for SCLC [<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B7">7</xref>]. Standard chemotherapy for SCLC consisted of VP-16 and cisplatin (CDDP) for a long time [<xref ref-type="bibr" rid="B8">8</xref>]. Recently, combination irinotecan hydrochloride (CPT-11) and CDDP chemotherapy has been shown to be more effective for SCLC based on the results of phase II and phase III clinical trials [<xref ref-type="bibr" rid="B9">9</xref>-<xref ref-type="bibr" rid="B11">11</xref>]. Therefore, we used combination CPT-11 and CDDP chemotherapy to treat the present patient.</p>
      <p>We herein report a case with advanced GSCC that was successfully treated by surgery and subsequent combination CPT-11 and CDDP chemotherapy.</p>
    </sec>
    <sec>
      <title>Case presentation</title>
      <p>A 71-year-old Japanese male went to a local hospital for postoperative follow-up of colonic carcinoma. Then anemia was noted, and gastrointestinal endoscopy revealed a large ulcerated tumor around the esophagogastric junction. Tumor biopsy specimens showed adenocarcinoma, and he was admitted to Nagoya City University Hospital for curative treatment. His family history was unremarkable, and medical history included acute myocardial infarction, bladder carcinoma, and colon carcinoma. Laboratory data were within normal limits except for anemia indicated by a hemoglobin (Hb) level of 9.4 g/dL (normal range: 13.2 g/dL &lt; Hb &lt; 17.2 g/dL). Serum levels of carcinoembryonic antigen (CEA) and carbohydrate antigen 19&#x2013;9 (CA19-9) were also within normal limits: 1.6 ng/mL (normal range &lt;3.5 ng/mL) and 3.7 U/mL (normal range &lt;37 U/mL), respectively. On computed tomography (CT), the tumor appeared as a thickening of the gastric wall with metastasis to perigastric lymph nodes (LN) (Figure&#xA0;<xref ref-type="fig" rid="F1">1</xref>A). Re-examination with gastrointestinal endoscopy revealed a Borrmann type III tumor located around the esophagogastric junction, which was diagnosed as GSCC upon histological examination of a biopsy specimen at our hospital. After providing informed consent, and following a sufficiently detailed explanation about his disease, the patient wished to undergo surgery. Surgical resection by proximal gastrectomy was performed. While total gastrectomy is the standard treatment for such cases, proximal gastrectomy was selected during surgery, because his small bowel, which was one lump due to previous surgery, could not be elevated to allow Rou-en-Y reconstruction.</p>
      <fig id="F1" position="float">
        <label>Figure 1</label>
        <caption>
          <p>Tumor location and form</p>
          <p><bold>Tumor location and form.</bold>&#x2009;Abdominal computed tomography (CT) scans showed carcinoma at the esophagogastric junction (white arrow) and lymph node swelling (dotted arrow) before surgery <bold>(A)</bold>. Macroscopic findings of the resected stomach: a Borrmann type III tumor that measured approximately 100 mm in diameter was located around the esophagogastric junction <bold>(B)</bold>.</p>
        </caption>
        <graphic xlink:href="1477-7819-11-263-1"/>
      </fig>
      <p>Resected specimens showed a Borrmann type III tumor that measured approximately 100 mm in diameter around the esophagogastric junction (Figure&#xA0;<xref ref-type="fig" rid="F1">1</xref>B). Histopathologic examination revealed that the tumor consisted of small cancer cells with dense chromatin nuclei (Figure&#xA0;<xref ref-type="fig" rid="F2">2</xref>A). Immunohistochemically, the tumor cells were positive for synaptophysin (Figure&#xA0;<xref ref-type="fig" rid="F2">2</xref>B) and chromogranin A (Figure&#xA0;<xref ref-type="fig" rid="F2">2</xref>C). The final histological diagnosis was GSCC. The pathological stage was IIIA (T3, N1, M0) according to the classification proposed by the Japanese Gastric Cancer Association [<xref ref-type="bibr" rid="B12">12</xref>].</p>
      <fig id="F2" position="float">
        <label>Figure 2</label>
        <caption>
          <p>Microscopic examination of the tumor</p>
          <p><bold>Microscopic examination of the tumor.</bold>&#x2009;Hematoxylin and eosin staining demonstrated small cells with hyperchromatic nuclei and scant cytoplasm (x200) <bold>(A)</bold>. The tumor cells were positive for synaptophysin <bold>(B)</bold>&#x2009;and chromogranin A (x200) <bold>(C)</bold>.</p>
        </caption>
        <graphic xlink:href="1477-7819-11-263-2"/>
      </fig>
      <p>After obtaining informed consent from the patient, we started the systemic chemotherapy with CPT-11 and CDDP. On day 1, CPT-11 (60 mg/m<sup>2</sup>) was administered, followed by administration of CDDP (80 mg/m<sup>2</sup>) over 2 hours with adequate hydration. The same dose of CPT-11 was administered on day 15, and this regimen was repeated every 4 weeks. Although NCI-CTC grade 2 febrile neutropenia and diarrhea and grade 1 nausea were observed, these side effects were resolved following pharmacologic intervention with G-CSF and antidiarrheal medications. After three courses, the patient declined further chemotherapy due to unbearable side effects. After 12 months (4 months after chemotherapy was stopped), his CEA level increased from 1.6 ng/mL to 12 ng/mL. Cancer recurrence was confirmed in a regional lymph node on CT (Figure&#xA0;<xref ref-type="fig" rid="F3">3</xref>A). Although we suggested re-initiation of systemic chemotherapy, the patient declined treatment. Fourteen months after surgery, the patient died of hemorrhage due to esophageal ulcer and subsequent aspiration pneumonia (Figure&#xA0;<xref ref-type="fig" rid="F3">3</xref>B).</p>
      <fig id="F3" position="float">
        <label>Figure 3</label>
        <caption>
          <p>Postoperative course</p>
          <p><bold>Postoperative course.</bold>&#x2009;Five months after the last course of chemotherapy, computed tomography (CT) scans revealed a recurrent regional lymph node (arrow) but no recurrence in the liver <bold>(A)</bold>. A contemporary gastrointestinal endoscopy revealed hemorrhage from an esophagus longitudinal ulcer, but no carcinoma recurrence was apparent in the esophagus <bold>(B)</bold>.</p>
        </caption>
        <graphic xlink:href="1477-7819-11-263-3"/>
      </fig>
    </sec>
    <sec sec-type="discussion">
      <title>Discussion</title>
      <p>Small cell carcinoma is a malignant disease that is frequently observed in the lung [<xref ref-type="bibr" rid="B5">5</xref>]. While extrapulmonary small cell carcinoma has been reported in the gastrointestinal tract, head, neck, urinary tract, and genitals [<xref ref-type="bibr" rid="B13">13</xref>,<xref ref-type="bibr" rid="B14">14</xref>], incidence of extrapulmonary small cell carcinoma is much lower than that of SCLC. Among these cancers, primary GSCC is extremely rare. Matsusaka <italic>et al</italic>. first reported GSCC in 1976, and revealed that the incidence was less than 0.1% of all gastric carcinomas in Japan, even though the incidence of gastric adenocarcinoma in Japan is much higher than in other countries [<xref ref-type="bibr" rid="B3">3</xref>].</p>
      <p>It is generally difficult to diagnose GSCC preoperatively. Kusayanagi <italic>et al</italic>. reported that only 40% of patients with GSCC were diagnosed correctly before surgery [<xref ref-type="bibr" rid="B15">15</xref>]. This may be due to the fact that carcinoma cells can differentiate in many aspects. Matsui <italic>et al</italic>. also suggested that small cell carcinomas originate from totipotent primitive cells, which can result in dual or multiple differentiation into a mixture of small neoplastic cells, squamous cells, and adenocarcinomatous cells [<xref ref-type="bibr" rid="B16">16</xref>]. Furthermore, tumor cells may not be detectable in biopsy specimens, because GSCC proliferates in the submucosal layer in many cases. In the present case, adenocarcinoma was first diagnosed at a local hospital. however, re-examination at our hospital enabled a correct diagnosis by cell morphology and immunohistochemical findings.</p>
      <p>Immunohistochemical examination is well known to be valuable for the diagnosis of GSCC. GSCC is unique in its positive reactions to synaptophysin and chromogranin A, although 10-20% of GSCCs demonstrate negative reactions for these tumor markers [<xref ref-type="bibr" rid="B17">17</xref>]. Histologically, the features of GSCC are similar to those of SCLC: they have a scanty cytoplasm and small-sized oval nuclei with inconspicuous nucleoli [<xref ref-type="bibr" rid="B18">18</xref>,<xref ref-type="bibr" rid="B19">19</xref>]. Therefore, the final diagnosis of GSCC should be based on both morphologic features and immunohistochemical reactions. In the present patient, the final diagnosis of GSCC was achieved due to positivity for both markers and histopathologic characteristics similar to SCLC in the resected specimen.</p>
      <p>Like SCLC, GSCC is an aggressive disease and the clinical course is generally very poor. Previous reports revealed that almost every patient with GSCC dies within 1 year [<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B15">15</xref>], because GSCC shows a high incidence of vasculolymphatic invasion, marked deep infiltration, and distant metastases at diagnosis [<xref ref-type="bibr" rid="B16">16</xref>,<xref ref-type="bibr" rid="B20">20</xref>]. Unfortunately, there is no standard effective treatment strategy for GSCC. Various treatment modalities have been proposed including surgery, chemotherapy, radiation therapy, and various combination of the above [<xref ref-type="bibr" rid="B15">15</xref>,<xref ref-type="bibr" rid="B20">20</xref>]. Although surgery and/or adjuvant chemotherapy have been evaluated in several studies, the results have been unsatisfactory [<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B21">21</xref>-<xref ref-type="bibr" rid="B23">23</xref>]. Although the effects of the treatment based on radiation therapy for esophagus or thyroid small cell carcinomas were reported [<xref ref-type="bibr" rid="B24">24</xref>,<xref ref-type="bibr" rid="B25">25</xref>], radiation therapy for GSCC has not been reported. A few reports revealed that surgical resection appeared to be effective, with survival ranging from 9 months to more than 5 years for patients with GSCC limited to the stomach [<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B26">26</xref>,<xref ref-type="bibr" rid="B27">27</xref>]. In contrast, in another report, massive hepatic metastases occurred in a short period in a case with early-stage disease, and the patient died within 6 months after definitive surgery [<xref ref-type="bibr" rid="B28">28</xref>]. Most patients with GSCC receive combination therapy consisting of surgery and subsequent chemotherapy, similar to that used for conventional gastric cancer, which involves 5-FU-based chemotherapy [<xref ref-type="bibr" rid="B6">6</xref>]. Nevertheless, no standard treatment strategy has been established for GSCC due to insufficient efficacy. Furthermore, the prognosis in GSCC is poorer than that for gastric adenocarcinoma, particularly in patients with advanced-stage diseases: the reported median survival for GSCC is 7 months [<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B16">16</xref>,<xref ref-type="bibr" rid="B28">28</xref>]. Treatment of GSCC with chemotherapy regimens used in SCLC may be more effective than other regimens. In fact, some reports have revealed that some SCLC chemotherapy regimens are also effective against GSCC [<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B29">29</xref>]. The most commonly used combination chemotherapy regimen for patients with SCLC is etoposide and CDDP [<xref ref-type="bibr" rid="B8">8</xref>]. This regimen yields an overall response rate of 80-95% in patients with limited disease and 60-80% in those with extensive disease [<xref ref-type="bibr" rid="B30">30</xref>]. Recently, combination CPT-11 and CDDP chemotherapy has also been shown to be effective for SCLC. The results of a phase III trial that compared CPT-11 and CDDP with CDDP and etoposide indicated that the overall response rate in the CPT-11 and CDDP group was significantly higher than that in the CDDP and etoposide group. Moreover, the median survival rate was 12.8 months in the CPT-11 and CDDP group compared to 9.4 months in the CDDP and etoposide group [<xref ref-type="bibr" rid="B11">11</xref>]. Based on the results of this trial, we elected to use a combination CPT-11 and CDDP regimen in the present patient. After three cycles of treatment, the patient experienced National Cancer Institute&#x2019;s Common Toxicity Criteria (NCI-CTC) grade 2 febrile neutropenia and diarrhea, and grade 1 nausea. The patient was sensitive to these side effects and refused further chemotherapy or alternate therapy. However, his duration of response and progression-free survival continued for approximately 1 year. Although previous reports revealed that almost all patients die within 6 months of being diagnosed with GSCC [<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B15">15</xref>,<xref ref-type="bibr" rid="B16">16</xref>], this patient survived for longer than 1 year with a satisfactory quality of life. Unfortunately, he died due to hemorrhage from an esophageal ulcer and subsequent aspiration pneumonia. It was not determined whether the esophageal ulcer was due to disease recurrence. However, recurrence was not observed in the esophageal mucosa, and no recurrence was present in the liver. If he had undergone continuous chemotherapy, he may have survived for a longer time.</p>
    </sec>
    <sec sec-type="conclusions">
      <title>Conclusions</title>
      <p>Because the incidence of GSCC is very low, no standard treatment strategy has been established. Indeed, effective surgical treatment is needed and subsequent intensive chemotherapy should be considered to promote long-term survival. Combination chemotherapy consisting of CPT-11 and CDDP appears to be effective for the treatment of primary GSCC. Further trials and experience in additional cases are required to fully evaluate the efficacy of this CPT-11 and CDDP regimen and to help establish the best treatment strategy for patients with GSCC.</p>
    </sec>
    <sec>
      <title>Consent</title>
      <p>Written informed consent was obtained from the patient&#x2019;s family for the publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.</p>
    </sec>
    <sec>
      <title>Abbreviations</title>
      <p>CA19-9: Carbohydrate antigen 19&#x2013;9; CDDP: Cisplatin; CEA: Carcinoembryonic antigen; CPT-11: Irinotecan hydrochloride; CT: Computed tomography; GSCC: Gastric small cell carcinoma; Hb: Hemoglobin; LN: Lymph nodes; NCI-CTC: National Cancer Institute&#x2019;s common toxicity criteria; NETs: Neuroendocrine tumors; SCLC: Small cell lung carcinoma.</p>
    </sec>
    <sec>
      <title>Competing interests</title>
      <p>Each co-author certifies that he has no commercial interest that might constitute a competing interest in connection with the submitted article.</p>
    </sec>
    <sec>
      <title>Authors&#x2019; contributions</title>
      <p>HF was responsible for the writing. TW, YM, and HI participated in data collection. HM, MK, and HT participated in literature searching. All authors have read and approved the final manuscript.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <ref id="B1">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Jemal</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Bray</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Center</surname>
            <given-names>MM</given-names>
          </name>
          <name>
            <surname>Ferlay</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Ward</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Forman</surname>
            <given-names>D</given-names>
          </name>
          <article-title>Global cancer statistics</article-title>
          <source>CA Cancer J Clin</source>
          <year>2011</year>
          <volume>61</volume>
          <fpage>69</fpage>
          <lpage>90</lpage>
          <pub-id pub-id-type="doi">10.3322/caac.20107</pub-id>
          <pub-id pub-id-type="pmid">21296855</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B2">
        <mixed-citation publication-type="other">
          <collab>The Editorial Board of the Cancer Statistics in Japan</collab>
          <source>CANCER STATISTICS IN JAPAN 2003</source>
          <comment>
            <ext-link ext-link-type="uri" xlink:href="http://www.fpcr.or.jp">http://www.fpcr.or.jp</ext-link>
          </comment>
        </mixed-citation>
      </ref>
      <ref id="B3">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Matsusaka</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Watanabe</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Enjoji</surname>
            <given-names>M</given-names>
          </name>
          <article-title>Oat-cell carcinoma of the stomach</article-title>
          <source>Fukuoka Igaku Zassi</source>
          <year>1976</year>
          <volume>67</volume>
          <fpage>65</fpage>
          <lpage>73</lpage>
        </mixed-citation>
      </ref>
      <ref id="B4">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Van Der Gaast</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Verwey</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Prins</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Splinter</surname>
            <given-names>TA</given-names>
          </name>
          <article-title>Chemotherapy as treatment of choice in extrapulmonary undifferentiated small cell carcinoma</article-title>
          <source>Cancer</source>
          <year>1990</year>
          <volume>65</volume>
          <fpage>422</fpage>
          <lpage>424</lpage>
          <pub-id pub-id-type="doi">10.1002/1097-0142(19900201)65:3&lt;422::AID-CNCR2820650308&gt;3.0.CO;2-Y</pub-id>
          <pub-id pub-id-type="pmid">1688727</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B5">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Am</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Otrakji</surname>
            <given-names>CL</given-names>
          </name>
          <name>
            <surname>Hussein</surname>
            <given-names>BT</given-names>
          </name>
          <article-title>Small cell carcinoma of the stomach. Case report and review of the literature</article-title>
          <source>Dig Dis Sci</source>
          <year>1990</year>
          <volume>35</volume>
          <fpage>513</fpage>
          <lpage>518</lpage>
          <pub-id pub-id-type="doi">10.1007/BF01536928</pub-id>
          <pub-id pub-id-type="pmid">2156662</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B6">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Arai</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Matsuda</surname>
            <given-names>M</given-names>
          </name>
          <article-title>Gastric small cell carcinoma in Japan. A case report and review of the literature</article-title>
          <source>Am J Clin Oncol</source>
          <year>1998</year>
          <volume>21</volume>
          <fpage>458</fpage>
          <lpage>461</lpage>
          <pub-id pub-id-type="doi">10.1097/00000421-199810000-00007</pub-id>
          <pub-id pub-id-type="pmid">9781599</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B7">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Matsui</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Kataoka</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Sugita</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Itoh</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Ichikawa</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Horisawa</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Koide</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Ichihara</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Nakao</surname>
            <given-names>A</given-names>
          </name>
          <article-title>A case of small cell carcinoma of the stomach</article-title>
          <source>Hepatogastroenterology</source>
          <year>1997</year>
          <volume>44</volume>
          <fpage>156</fpage>
          <lpage>160</lpage>
          <pub-id pub-id-type="pmid">9058136</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B8">
        <mixed-citation publication-type="other">
          <collab>National Comprehensive Cancer network</collab>
          <source>Clinical Practice Guidelines in Oncology. Small Cell Lung Cancer</source>
          <comment>
            <ext-link ext-link-type="uri" xlink:href="http://www.nccn.org/professionals/physician_gls/PDF/sclc.pdf">http://www.nccn.org/professionals/physician_gls/PDF/sclc.pdf</ext-link>
          </comment>
        </mixed-citation>
      </ref>
      <ref id="B9">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Kudoh</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Fujiwara</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Takada</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Yamamoto</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Kinoshita</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Ariyoshi</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Furuse</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Fukuoka</surname>
            <given-names>M</given-names>
          </name>
          <article-title>Phase II study of irinotecan combined with cisplatin in patients with previously untreated small-cell lung cancer. West Japan lung cancer group</article-title>
          <source>J Clin Oncol</source>
          <year>1998</year>
          <volume>16</volume>
          <fpage>1068</fpage>
          <lpage>1074</lpage>
          <pub-id pub-id-type="pmid">9508192</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B10">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Boku</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Ohtsu</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Shimada</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Shirao</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Seki</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Saito</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Sakata</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Hyodo</surname>
            <given-names>I</given-names>
          </name>
          <article-title>Phase II study of a combination of irinotecan and cisplatin against metastatic gastric cancer</article-title>
          <source>J Clin Oncol</source>
          <year>1999</year>
          <volume>17</volume>
          <fpage>319</fpage>
          <lpage>323</lpage>
          <pub-id pub-id-type="pmid">10458249</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B11">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Noda</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Nishiwaki</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Kawahara</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Negoro</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Sugiura</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Yokoyama</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Fukuoka</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Mori</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Watanabe</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Tamura</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Yamamoto</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Saijo</surname>
            <given-names>N</given-names>
          </name>
          <collab>Japan Clinical Oncology Group</collab>
          <article-title>Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer</article-title>
          <source>N Engl J Med</source>
          <year>2002</year>
          <volume>346</volume>
          <fpage>85</fpage>
          <lpage>91</lpage>
          <pub-id pub-id-type="doi">10.1056/NEJMoa003034</pub-id>
          <pub-id pub-id-type="pmid">11784874</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B12">
        <mixed-citation publication-type="journal">
          <collab>Japanese Gastric Cancer Association</collab>
          <article-title>Japanese classification of gastric carcinoma, 2nd English edition</article-title>
          <source>Gastric Cancer</source>
          <year>1998</year>
          <volume>1</volume>
          <fpage>10</fpage>
          <lpage>24</lpage>
          <pub-id pub-id-type="pmid">11957040</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B13">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Namikawa</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Kobayashi</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Okabayashi</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Ozaki</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Nakamura</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Yamashita</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Ueta</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Miyazaki</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Tamura</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Ohtsuki</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Araki</surname>
            <given-names>K</given-names>
          </name>
          <article-title>Primary gastric small cell carcinoma: report of a case and review of the literature</article-title>
          <source>Med Mol Morphol</source>
          <year>2005</year>
          <volume>38</volume>
          <fpage>256</fpage>
          <lpage>261</lpage>
          <pub-id pub-id-type="doi">10.1007/s00795-005-0293-4</pub-id>
          <pub-id pub-id-type="pmid">16378235</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B14">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Kim</surname>
            <given-names>JH</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>SH</given-names>
          </name>
          <name>
            <surname>Paek</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Kim</surname>
            <given-names>HY</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>SI</given-names>
          </name>
          <name>
            <surname>Nam</surname>
            <given-names>WM</given-names>
          </name>
          <name>
            <surname>Park</surname>
            <given-names>JO</given-names>
          </name>
          <name>
            <surname>Kim</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Jung</surname>
            <given-names>CW</given-names>
          </name>
          <name>
            <surname>Im</surname>
            <given-names>YH</given-names>
          </name>
          <name>
            <surname>Kang</surname>
            <given-names>WK</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>MH</given-names>
          </name>
          <name>
            <surname>Park</surname>
            <given-names>K</given-names>
          </name>
          <article-title>Extrapulmonary small-cell carcinoma: a single-institution experience</article-title>
          <source>Jpn J Clin Oncol</source>
          <year>2004</year>
          <volume>34</volume>
          <fpage>250</fpage>
          <lpage>254</lpage>
          <pub-id pub-id-type="doi">10.1093/jjco/hyh052</pub-id>
          <pub-id pub-id-type="pmid">15231859</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B15">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Kusayanagi</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Konishi</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Miyasaka</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Sasaki</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Kurahashi</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Kaneko</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Akita</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Yoshikawa</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Kusano</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Yamochi</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Kushima</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Mitamura</surname>
            <given-names>K</given-names>
          </name>
          <article-title>Primary small cell carcinoma of the stomach</article-title>
          <source>J Gastroenterol Hepatol</source>
          <year>2003</year>
          <volume>18</volume>
          <fpage>743</fpage>
          <lpage>747</lpage>
          <pub-id pub-id-type="doi">10.1046/j.1440-1746.2003.02822.x</pub-id>
          <pub-id pub-id-type="pmid">12753162</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B16">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Matsui</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Kitagawa</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Miwa</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Kuroda</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Tsuji</surname>
            <given-names>M</given-names>
          </name>
          <article-title>Small cell carcinoma of the stomach: a clinicopathologic study of 17 cases</article-title>
          <source>Am J Gastroenterol</source>
          <year>1991</year>
          <volume>86</volume>
          <fpage>1167</fpage>
          <lpage>1175</lpage>
          <pub-id pub-id-type="pmid">1715667</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B17">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Tanemura</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Ohshita</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Kanno</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Kusakabe</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Tomita</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Nishigaki</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Sugiyama</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Yamada</surname>
            <given-names>T</given-names>
          </name>
          <article-title>A patient with small-cell carcinoma of the stomach with long term survival after percutaneous microwave coagulating therapy (PMCT) for liver metastasis</article-title>
          <source>Int J Clin Oncol</source>
          <year>2002</year>
          <volume>7</volume>
          <fpage>128</fpage>
          <lpage>132</lpage>
          <pub-id pub-id-type="pmid">12018111</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B18">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Cohen</surname>
            <given-names>MH</given-names>
          </name>
          <name>
            <surname>Matthews</surname>
            <given-names>MJ</given-names>
          </name>
          <article-title>Small cell bronchogenic carcinoma: a distinct clinicopayhologic entity</article-title>
          <source>Semin Oncol</source>
          <year>1978</year>
          <volume>5</volume>
          <fpage>234</fpage>
          <lpage>243</lpage>
          <pub-id pub-id-type="pmid">211637</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B19">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Levenson</surname>
            <given-names>RM</given-names>
            <suffix>Jr</suffix>
          </name>
          <name>
            <surname>Ihde</surname>
            <given-names>DC</given-names>
          </name>
          <name>
            <surname>Matthews</surname>
            <given-names>MJ</given-names>
          </name>
          <name>
            <surname>Cohen</surname>
            <given-names>MH</given-names>
          </name>
          <name>
            <surname>Gazdar</surname>
            <given-names>AF</given-names>
          </name>
          <name>
            <surname>Bunn</surname>
            <given-names>PA</given-names>
            <suffix>Jr</suffix>
          </name>
          <name>
            <surname>Minna</surname>
            <given-names>JD</given-names>
          </name>
          <article-title>Small cell carcinoma presenting as an extrapulmonary neoplasm: sites of origin and response to chemotherapy</article-title>
          <source>J Natl Cancer Inst</source>
          <year>1981</year>
          <volume>67</volume>
          <fpage>607</fpage>
          <lpage>612</lpage>
          <pub-id pub-id-type="pmid">6268879</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B20">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Iwamuro</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Tanaka</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Bessho</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Takahashi</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Ohta</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Takada</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Murakami</surname>
            <given-names>I</given-names>
          </name>
          <article-title>Two cases of primary small cell carcinoma of the stomach</article-title>
          <source>Acta Med Okayama</source>
          <year>2009</year>
          <volume>63</volume>
          <fpage>293</fpage>
          <lpage>298</lpage>
          <pub-id pub-id-type="pmid">19893606</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B21">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Kaizaki</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Fujii</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Kawai</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Saito</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Kurihara</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Fukayama</surname>
            <given-names>M</given-names>
          </name>
          <article-title>Gastric neuroendocrine carcinoma associated with chronic atrophic gastritis type A</article-title>
          <source>J Gastroenterol</source>
          <year>1997</year>
          <volume>32</volume>
          <fpage>643</fpage>
          <lpage>649</lpage>
          <pub-id pub-id-type="doi">10.1007/BF02934114</pub-id>
          <pub-id pub-id-type="pmid">9349990</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B22">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Eriguchi</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Aoyagi</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Hara</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Sakai</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Imayama</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Tanaka</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Hashimoto</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Imamura</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Kage</surname>
            <given-names>M</given-names>
          </name>
          <article-title>Gastric enterochromaffin-like-cell tumor with liver and splenic metastases</article-title>
          <source>J Gastroenterol</source>
          <year>1999</year>
          <volume>34</volume>
          <fpage>383</fpage>
          <lpage>386</lpage>
          <pub-id pub-id-type="doi">10.1007/s005350050279</pub-id>
          <pub-id pub-id-type="pmid">10433017</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B23">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Nakamura</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Otani</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Otaka</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Shimada</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Takahashi</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Saito</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Takahashi</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Komatsu</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Suzuki</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Okubo</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Hayashi</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Sasano</surname>
            <given-names>H</given-names>
          </name>
          <article-title>Gastric small cell carcinoma with marked response to neoadjuvant chemotherapy</article-title>
          <source>Int J Clin Oncol</source>
          <year>2005</year>
          <volume>10</volume>
          <fpage>348</fpage>
          <lpage>352</lpage>
          <pub-id pub-id-type="doi">10.1007/s10147-005-0492-y</pub-id>
          <pub-id pub-id-type="pmid">16247663</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B24">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Ohmura</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Takiyama</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Mandai</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Doi</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Nishikawa</surname>
            <given-names>Y</given-names>
          </name>
          <article-title>Small cell carcinoma of the esophagus: a case report</article-title>
          <source>Jpn J Clin Oncol</source>
          <year>1997</year>
          <volume>27</volume>
          <fpage>95</fpage>
          <lpage>100</lpage>
          <pub-id pub-id-type="doi">10.1093/jjco/27.2.95</pub-id>
          <pub-id pub-id-type="pmid">9152798</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B25">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Beach</surname>
            <given-names>DF</given-names>
          </name>
          <name>
            <surname>Klump</surname>
            <given-names>WJ</given-names>
          </name>
          <name>
            <surname>Haddad</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Reid</surname>
            <given-names>LM</given-names>
          </name>
          <name>
            <surname>Schwarting</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Hageboutros</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Extrapulmonary small cell: a novel case of small cell carcinoma of the thyroid gland</article-title>
          <source>Med Oncol</source>
          <year>2012</year>
          <volume>29</volume>
          <fpage>1405</fpage>
          <lpage>1408</lpage>
          <pub-id pub-id-type="doi">10.1007/s12032-011-9996-7</pub-id>
          <pub-id pub-id-type="pmid">21644012</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B26">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Ibrahim</surname>
            <given-names>NBN</given-names>
          </name>
          <name>
            <surname>Briggs</surname>
            <given-names>JC</given-names>
          </name>
          <name>
            <surname>Corbishley</surname>
            <given-names>CM</given-names>
          </name>
          <article-title>Extrapulmonary oat cell carcinoma</article-title>
          <source>Cancer</source>
          <year>1984</year>
          <volume>54</volume>
          <fpage>1645</fpage>
          <lpage>1661</lpage>
          <pub-id pub-id-type="doi">10.1002/1097-0142(19841015)54:8&lt;1645::AID-CNCR2820540828&gt;3.0.CO;2-Q</pub-id>
          <pub-id pub-id-type="pmid">6089995</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B27">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Haratake</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Horie</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Inoshita</surname>
            <given-names>S</given-names>
          </name>
          <article-title>Gastric small cell carcinoma with squamous and neuroendocrine differentiation</article-title>
          <source>Pathology</source>
          <year>1992</year>
          <volume>24</volume>
          <fpage>116</fpage>
          <lpage>120</lpage>
          <pub-id pub-id-type="doi">10.3109/00313029209063636</pub-id>
          <pub-id pub-id-type="pmid">1322519</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B28">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Fukuda</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Ohnishi</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Nishimaki</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Ohtani</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Tachikawa</surname>
            <given-names>S</given-names>
          </name>
          <article-title>Early gastric cancer of the small cell type</article-title>
          <source>Am J Gastroenterol</source>
          <year>1988</year>
          <volume>83</volume>
          <fpage>1176</fpage>
          <lpage>1179</lpage>
          <pub-id pub-id-type="pmid">2844080</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B29">
        <mixed-citation publication-type="journal">
          <name>
            <surname>O&#x2019;Byrne</surname>
            <given-names>KJ</given-names>
          </name>
          <name>
            <surname>Cherukuri</surname>
            <given-names>AK</given-names>
          </name>
          <name>
            <surname>Khan</surname>
            <given-names>MI</given-names>
          </name>
          <name>
            <surname>Farrell</surname>
            <given-names>RJ</given-names>
          </name>
          <name>
            <surname>Daly</surname>
            <given-names>PA</given-names>
          </name>
          <name>
            <surname>Sweeney</surname>
            <given-names>EC</given-names>
          </name>
          <name>
            <surname>Keeling</surname>
            <given-names>PW</given-names>
          </name>
          <article-title>Extrapulmonary small cell gastric carcinoma. A case report and review of the literature</article-title>
          <source>Acta Oncol</source>
          <year>1997</year>
          <volume>36</volume>
          <fpage>78</fpage>
          <lpage>80</lpage>
          <pub-id pub-id-type="doi">10.3109/02841869709100738</pub-id>
          <pub-id pub-id-type="pmid">9090972</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B30">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Zochbauer-Muller</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Pirker</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Huber</surname>
            <given-names>H</given-names>
          </name>
          <article-title>Treatment of small cell lung cancer patients</article-title>
          <source>Ann Oncol</source>
          <year>1999</year>
          <volume>10</volume>
          <fpage>S83</fpage>
          <lpage>S91</lpage>
          <pub-id pub-id-type="pmid">10582146</pub-id>
        </mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
